Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
05/2007
05/09/2007EP1781593A2 Cationic lipids and methods of use
05/09/2007CN1960965A Synthesis of amino-alkoxy-heptanoic alkyl ester
05/09/2007CN1314655C Method for preparing 4-nitroso-substituted aromatic amine
05/08/2007US7214806 Synthetic multiple quaternary ammonium salts
05/08/2007US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
05/03/2007WO2007051198A2 Photo-responsive microencapsulation materials, compositions and methods of use thereof
05/03/2007WO2007014973A3 Method of obtaining phenyl carbamates
05/03/2007US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
05/03/2007US20070099079 Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery
05/03/2007CA2627648A1 Photo-responsive microencapsulation materials, compositions and methods of use thereof
05/02/2007EP1778619A2 T type calcium channel inhibitors
05/02/2007EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
05/02/2007EP1322590B1 5-amino-1-pentene-3-ol substituted derivatives
05/02/2007EP1299342B1 Method for producing 3,3-diarylpropylamines
05/02/2007EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
05/02/2007CN1956970A Substituted pyrazinecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agricultural/horticultural agent and use thereof
05/02/2007CN1956969A 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and 5-serotonin reuptake inhibitors
05/02/2007CN1956945A P-terphenyl compound and photosensitive body for electrophotography using such compound
05/02/2007CN1955159A Composite for blocking 5-hydroxytryptamine and norepinephrine reabsorbed, its preparation method and its use
05/01/2007US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor
05/01/2007US7211694 Substituted 4-aminocyclohexanols
05/01/2007US7211685 Carboxy group, nitro group, tert-butoxycarbonylamino group or benzyloxycarbonylamino substituted naphthalene: osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia
05/01/2007CA2271004C Process for the preparation of optically pure isomers of formoterol
04/2007
04/26/2007WO2007047972A2 Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
04/26/2007WO2007045857A1 Novel process
04/26/2007WO2007017267A3 Novel compounds
04/26/2007WO2006072785A3 Base stable ionic liquids
04/26/2007WO2006072775A3 Ionic liquids with a cation comprising a basic moiety
04/26/2007US20070093556 Toremifene crystallization method
04/26/2007US20070093476 Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
04/26/2007CA2838520A1 Novel process
04/26/2007CA2625832A1 Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
04/26/2007CA2625337A1 Novel process
04/25/2007EP1777214A2 Novel aryloxy-alkyl-dialkylamines
04/25/2007CN1312535C Optical photoresist stripping composition
04/25/2007CN1312125C Amino alcohol derivative, addition salt thereof, and immunosuppressant
04/25/2007CN1312116C Calcium acceptor active compound
04/25/2007CN1312115C Chiral 1,4 diamidogen and its complex of platinum II
04/25/2007CN1312114C Compound of aroma dihydroxy diamines and preparation method
04/25/2007CN1312111C Process for preparing 2-[(dimethylamino)-methyl]-1-(3-methoxyphenyl)cyclohexanol
04/24/2007USRE39593 Diastereoisomers with an analgesic effect; suitable for the treatment of severe pain without the side effects of opioids
04/24/2007USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations
04/24/2007US7208520 Crystals of hydroxynorephedrine derivative
04/19/2007WO2007017544A3 Method of obtaining 3,3-diphenylpropylamines
04/18/2007CN1950385A Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts
04/18/2007CN1950326A Process for the optical resolution and recycling of tomoxetine
04/18/2007CN1950325A Process for the preparation of atomoxetine hydrochloride
04/18/2007CN1948277A Propylamine derivative and its application in preparing tomocetin
04/18/2007CN1948276A Improved preparation method of flurazetin
04/18/2007CN1948275A Verakanol Mannich alkali derivative, its preparation method and use
04/18/2007CN1948274A Verakanol derivative, its preparation method and use
04/18/2007CN1948266A Method of preparing N-mono substituted benzylamine by catalytic hydrogenation reduction amination
04/18/2007CN1948265A Nitrobenzene derivative containing phenoxy and its preparation method
04/18/2007CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I
04/18/2007CN1310871C Preparation of N-methylated amines from selective vapor phase amination of amino ether alcohols
04/17/2007US7205425 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof
04/17/2007US7205320 Such as 3-[3-(4-chlorophenyl)prop-1-yloxy]-4-methoxy-N-(3-pyridylmethyl)diphenylamine; reduced emetic side effect; neurological syndromes
04/17/2007CA2348725C Vitamin d analogues
04/12/2007WO2007039125A2 An optically active thyroid receptor agonist and optically active key intermediates in its production
04/12/2007WO2007021462A3 Alkylamino alkyloxy (alcohol) monoalkyl ether for acid gas scrubbing process
04/12/2007WO2007015002A3 Novel crystalline iv form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form
04/12/2007WO2006136682A3 Method for preparing fatty-chain branched triamines and ether diamines
04/11/2007EP1439164B1 Novel phenylethanolamine compounds having beta2-acceptor excitatory function and their preparation method
04/11/2007EP1228035B1 Laundry detergent compositions comprising hydrophobically modified polyamines
04/11/2007EP1207868B1 Pharmaceutical tramadol salts
04/11/2007EP0787122B1 Calcium receptor-active compounds
04/11/2007CN1946679A Amino-propanol derivatives
04/11/2007CN1946678A Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards
04/11/2007CN1946677A Enantiomerically pure atomoxetine and tomoxetine mandelate
04/10/2007US7202348 Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
04/10/2007US7202242 Substituted 1 and 2-naphthol Mannich bases
04/10/2007CA2337991C Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
04/05/2007WO2007036781A1 Diphenyl ether monoamine reuptake inhibitor
04/05/2007WO2007036712A1 Ionic liquids
04/05/2007WO2007036496A1 Method for preparing aminodiglycol (adg) and morpholine
04/05/2007US20070078139 Phosphodiesterase 4 inhibitors
04/05/2007US20070077506 Electrophotographic photoreceptor and image forming apparatus provided with the same
04/04/2007EP1770083A1 Inorganic ion receptor-active compounds
04/04/2007EP1768949A2 Polymorphs of atomoxetiene hydrochloride
04/04/2007EP1332139B1 Anticancer agents based on regulation of protein prenylation
04/04/2007CN1942429A Processes for the preparation of tomoxetine
04/04/2007CN1939891A Pharmaceutical synthesis of 4-methoxy-alpha-methyl-phenethylamine
04/04/2007CN1308332C Method for preparation of aryl ethers
04/04/2007CN1308283C Intermediate in producing phenoxyacetic acid derivatives and method for using same
04/03/2007US7199239 Chemical compounds
03/2007
03/29/2007WO2007034924A1 METALLO-β-LACTAMASE INHIBITOR
03/29/2007US20070072859 Pharmaceutical compounds
03/29/2007CA2620675A1 Metallo-.beta.-lactamase inhibitors
03/28/2007EP1765267A1 Initial phenylpropanediol dye products
03/28/2007EP1138745B1 Organic electroluminescent element
03/28/2007CN1938262A Quaternary ammonium compound, method for production thereof, and therapeutic agent for cerebrovascular disorder and heat disease
03/27/2007USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations
03/27/2007US7196225 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/27/2007US7196084 Cdc25 phosphatase inhibitors
03/27/2007CA2180841C 1-aminoindan derivatives and compositions thereof
03/22/2007WO2006133339A3 Monoamine re-uptake inhibitors and methods relating thereto
03/22/2007US20070066658 N-{4-[4-(2-Benzylamino-ethyl)-phenoxy]-phenyl}-acetamide; eating disorders; antidiabetic, -arthritic, -epileptic, anxiolytic -lipedemic agents; anxiolytic, hypoglycemic and hypotensive agents; sexual disorders, antidepressants, hypertriglycemia, hyperlipoproteinemia, drug abuse; behavior disorders
03/21/2007CN1934071A Formamide derivatives useful as adrenoceptor
03/21/2007CN1934067A Preparation of levalbuterol hydrochloride
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 140